Screener
Revolution Medicines, Inc. RVMD Enterprise value
Enterprise value at other companies
Other financials
Where this comes from
Calculated from Revolution Medicines, Inc.’s reported figures.
The source filing: Revolution Medicines, Inc.’s 10-Q, filed May 6, 2026. Open the filing →
- Filed
- May 6, 2026, 4:10 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001193125-26-208969
FAQ
- What is Revolution Medicines, Inc.'s enterprise value?
- Revolution Medicines, Inc. (RVMD) reported enterprise value of $18.99B in Q1 2026.
- How has Revolution Medicines, Inc.'s enterprise value changed year-over-year?
- Revolution Medicines, Inc.'s enterprise value increased by 197.9% year-over-year, from $6.37B to $18.99B.
- What is the long-term trend for Revolution Medicines, Inc.'s enterprise value?
- Over 5 years (2020 to 2025), Revolution Medicines, Inc.'s enterprise value has grown at a 41.1% compound annual growth rate (CAGR), from $2.72B to $15.17B.
- What does enterprise value mean?
- Market capitalization plus total debt minus cash, at the quarter end. The cost to acquire the whole business — what an buyer pays for equity and debt, net of the cash they'd inherit.
Ask your AI about Revolution Medicines, Inc.'s enterprise value.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude